Home › Funds › Carmignac Gestion › IONS

Carmignac Gestion position in IONS

IONIS PHARMACEUTICALS INC · Health Care

Carmignac Gestion reported holding 754,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$33.7M, representing 0.54% of its reported portfolio and ranking #39 among its reported holdings. Carmignac Gestion has disclosed IONS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)754.00K sh
Reported value held$33.67M
Portfolio Weight0.54%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Carmignac Gestion's IONS position evolved

Carmignac Gestion first disclosed a stake in IONS in Q1 2026 at 53,000 shares (US$4.0M). The position peaked in Q3 2026 at 754,000 shares, worth US$33.7M. Across 3 filings, Carmignac Gestion increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 754,000 shares valued at US$33.7M — an increase of 433,000 shares quarter over quarter.. Notable position changes include a 506% increase in Q2 2026 (shares fell 44% over the following quarter), a 135% increase in Q3 2026 (shares fell 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 53.00K $3.98M New
Q2 2026 321.00K $25.45M Add
Q3 2026 754.00K $33.67M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 34 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Deep Track Capital, LP (US$174.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has Carmignac Gestion held IONS?

Carmignac Gestion has disclosed IONS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Carmignac Gestion's current position in IONS?

As of Q3 2026, Carmignac Gestion holds 754.00K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $33.67M, representing 0.54% of its reported portfolio and ranking #39.

Has Carmignac Gestion been buying or selling IONS?

In the latest 13F filing (Q3 2026), Carmignac Gestion increased its position in IONS. The position peaked in Q3 2026 at 754.00K shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Deep Track Capital, LP, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.